Proprietary mouse-derived monoclonal antibodies specific to human soluble Toll-like receptor 2. Available for research and commercial applications in diagnostic assay development and immunological studies.
Manufactured by
J R Biomedical Ltd
St Asaph, United Kingdom
With applications in sepsis and inflammation, we have developed in cooperation with Cardiff University, a 10 minute rapid test and proprietary panel of monoclonal and polyclonal antibodies, that detect the innate immune system biomarker soluble Toll-like receptor 2 (sTLR2). UKCA certified ISO13485:2016 certified Results in 10 minutes 20µL blood sample J R Biomedical Ltd. is a British ISO13485 certified in-vitro diagnostics company who have developed a panel of proprietary antibodies, and a rapid diagnostic IVD to detect plasma soluble Toll-like receptor 2 (sTLR2), a biomarker known to be elevated in sepsis. UK Patent Application GB2502531.3. An independent study of sTLR2 versus CRP in critically ill patients showed that sTLR2 had better specificity and sensitivity for sepsis than C-reactive protein, the most commonly used marker in the ICU. Further, low sTLR2 levels had good ability to rule out sepsis within the first 12 h of ICU stay, when clinical parameters and traditional markers of infection are often equivocal.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SYnAbs S.A.
Belgium · 9 relevant products
quartett Biotechnologie GmbH
Germany · 1 relevant product
Rekom Biotech S.L.
Spain · 1 relevant product
19 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 30 closest product alternatives
SYnAbs S.A. · Belgium
Rat-derived secondary monoclonal antibodies targeting human antigens for research and diagnostic applications. Engineered to recognize complex transmembrane proteins, haptens, small molecules, and post-translational modifications with high specificity. Utilizes proprietary SYnDNA vector and syngeneic cell technologies to achieve functional antibodies for immunoassays and therapeutic development.
SYnAbs S.A. · Belgium
Rat-LOU secondary monoclonal antibodies targeting mouse antigens, engineered for high specificity and affinity in diagnostic and research applications. These antibodies enable detection of complex transmembrane proteins, small molecules, post-translational modifications, and difficult antigens in immunoassays and laboratory workflows. Generated through proprietary SYnDNA vector and syngeneic cell technologies with natural in-vivo maturation for enhanced epitope recognition.
SYnAbs S.A. · Belgium
Rat secondary monoclonal antibodies targeting anti-species isotypes for use in diagnostic immunoassays and research applications. These antibodies enable detection and quantification of primary antibodies in various diagnostic and analytical workflows. Produced using proprietary rat-LOU species technology, they deliver high specificity and affinity for complex antigens including transmembrane proteins, small molecules, and post-translational modifications.
27 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products